Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standardized Contrast-enhanced Ultrasound (CEUS) -Algorithms for the Non-invasive Diagnosis of Hepatocellular Carcinoma (HCC) in High-risk-patients - a Prospective German Multicenter Study

NCT03405909 is registered in ClinicalTrials.gov with University Hospital Erlangen as lead sponsor.

NCT NCT03405909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03405909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standardized Contrast-enhanced Ultrasound (CEUS) -Algorithms for the Non-invasive Diagnosis of Hepatocellular Carcinoma (HCC) in High-risk-patients - a Prospective German Multicenter Study
Lead sponsor
University Hospital Erlangen
Phase
Observational
Overall status
Completed
Start date
April 21, 2018
Completion date
April 6, 2019
Enrollment
517 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, intrahepatic, hepatocellular carcinoma, liver cancer, liver cirrhosis, liver diseases, liver neoplasms